AlphaBioCom

AlphaBioCom is a life sciences services company focused on scientific and medical communications for pharmaceutical, biotech, and medical device/diagnostic clients. Founded in 2005 in the Philadelphia area, the company built capabilities in publication planning, manuscript and poster development, medical affairs communications, advisory boards, and payer/HEOR communications. In December 2022, AlphaGroup Medical Communications, which included AlphaBioCom, was acquired by Red Nucleus and integrated into its medical communications business unit. Today, the AlphaBioCom website and service offering operate within Red Nucleus, emphasizing technology-enabled medical communications, omnichannel engagement, and digital scientific content. The business is service-based rather than a therapeutic product developer, so it does not maintain a conventional drug pipeline.